Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
The most effective method to Really Adjust Hypothesis and Practice in Your Brain science Studies- The hunt for dark matter: a trivia quiz
- Sally Rooney books may be withdrawn from UK sale over Palestine Action ban, court told
- Remain Cool and Solid: Top Summer Food sources for 2024
- 5 Fundamental Ways to employ a Criminal Legal counselor
- IDF destroys two-kilometer-long Gaza terror tunnel in Beit Lahiya
- Greenland’s melting ice and landslide-prone fjords make the oil and minerals Trump is eyeing dangerous to extract
- Advocacy groups react after Mattel introduces 1st Barbie doll with autism
- The Benefits of Rehearsing Careful Nurturing
